Nautilus Biotechnology, Inc. Shareholders' Equity
Nautilus Biotechnology, Inc. (NAUT) had Shareholders' Equity of $131.11 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-28
- 2026-06-30: Stockholders' Equity Attributable to Parent $131.11M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $144.41M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $156.97M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $169.14M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $131.11M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $144.41M 10-Q · filed 2026-07-28 | |
| 2025-12-31 | $156.97M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $169.14M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $181.09M 10-Q · filed 2026-07-28 | |
| 2025-03-31 | $194.44M 10-Q · filed 2026-07-28 | |
| 2024-12-31 | $208.73M 10-Q · filed 2026-07-28 | |
| 2024-09-30 | $223.43M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $235.28M 10-Q · filed 2025-10-28 | |
| 2024-03-31 | $249.49M 10-Q · filed 2025-07-31 | |
| 2023-12-31 | $265.35M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $277.27M 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $289.67M 10-Q · filed 2024-10-29 | |
| 2023-03-31 | $303.71M 10-Q · filed 2024-07-30 | |
| 2022-12-31 | $314.92M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $325.34M 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $337.56M 10-Q · filed 2023-10-31 | |
| 2022-03-31 | $349.71M 10-Q · filed 2023-08-02 | |
| 2021-12-31 | $363.58M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $377.85M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $390.04M 10-Q · filed 2022-11-01 | |
| 2021-03-31 | -$36.80M 10-Q · filed 2022-08-02 | $5.00M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$29.72M 10-K · filed 2023-02-23 | $5.00M 10-K · filed 2021-03-30 |
| 2020-09-30 | -$24.62M 10-Q · filed 2021-11-02 | $5.00M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$20.73M 10-Q · filed 2021-11-02 | $13.28K 10-Q · filed 2020-09-18 |
| 2020-03-31 | -$17.39M 10-Q · filed 2021-08-10 | $25.00K 10-Q · filed 2020-11-13 |
| 2020-03-26 | $0.00 10-K · filed 2021-03-30 | |
| 2019-12-31 | -$14.51M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |